Send Email
Send SMS
Search
Angel Biogenics Private Limited
Angel Biogenics Private Limited


New Items

Offering you a complete choice of products which include bleomycin injection, doxorubicin hydrochloride injections, doxorubicin injections, paclitaxel injection 100mg, paclitaxel injection 300mg and paclitaxel injection 30mg.

Bleomycin Injection

REQUEST CALLBACK

Bleomycin  Injection
Ask for Price

Thanks for Contacting Us.

Product Price :Get Latest Price

We are one of the renowned manufacturers and exporters of Bleomycin Injection. Prepared as per the existing industrial procedures, these effective injections are widely used for squamous cell carcinoma and testicular carcinoma. Owing to the accurate composition and longer shelf life, the proffered injections are vastly appreciated and demanded among our precious patrons.

Features:

  • Enhanced shelf life
  • Precise composition
  • Effective

Indications:


As first line therapy and/or adjuvant to surgery and radiation therapy in:

  • Squamous Cell Carcinoma (Head and neck, skin, penis, cervix, and vulva)
  • Lymphomas (Hodgkin's Disease, Non-hodgkin's Lymphoma)
  • Testicular Carcinoma (Embryonal cell, choriocarcinoma and teratocarcinoma)
  • Treatment of malignant pleural effusion and prevention of recurrent pleural effusions

Dosage and Administration:

  • Squamous cell carcinoma, non hodgkins lymphoma, testicular carcinoma: 0.25 to 0.50 unit/kg (10 to 20 units/m2) given intravenously, intramuscularly or subcutaneously weekly or twice weekly
  • Hodgkins disease: 0.25 to 0.50 unit/kg (10 to 20 units/m2) given intravenously, intramuscularly, or subcutaneously weekly or twice weekly. After a 50% response, a maintenance dose fo 1 unit daily or 5 units weekly intravenously or intramuscularly should be given
  • Malignant pleural effusion: 60 units administered as a single dose bolus intrapleural injection

Patients with renal Insufficiency:

The following dosing reductions are proposed for patients with creatinine clearance (CrCL) values fo less the than 50 mL/min:
Patent CrCL (mL/min)Lyoble dose (%)
> 50100
40-5070
30-4060
20-3055
10-2045
5-1040
Yes! I am Interested

View PDF

Doxorubicin Hydrochloride Injections

REQUEST CALLBACK

Doxorubicin Hydrochloride Injections
Ask for Price

Thanks for Contacting Us.

Product Price :Get Latest Price

We are one of the trustworthy names in the business to manufacture, supply and export Doxorubicin Hydrochloride Injections. Processed from supreme quality ingredients, these effective injections find a vast application for treating bronchogenic carcinoma, acute myeloblastic leukemia transitional cell bladder carcinoma and soft tissue & bone sarcomas. Patrons can obtain the batch at market leading costs.

Features:

  • Longer shelf life
  • Correct composition
  • Hygienically packed

Indications:


  • Wilms tumor
  • Neuroblastoma
  • Hodgkins disease
  • Gastric carcinoma
  • Hodgkins disease
  • Breast carcinoma
  • Thyroid carcinoma
  • Ovarian carcinoma
  • Malignant lymphoma
  • Lymphoblastic leukemia
  • Bronchogenic carcinoma
  • Acute myeloblastic leukemia
  • Soft tissue and bone sarcomas
  • Transitional cell bladder carcinoma

Dosage and Administration:

  • 60-75 mg/m2 as a single intravenous injection administered every 3 weeks
  • Dose adjustment is required in hepatically impaired patients

Additional Information:

  • Item Code: 10mg-5ml
  • Yes! I am Interested

    View PDF

    Doxorubicin Injections

    REQUEST CALLBACK

    Doxorubicin Injections
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    Ours is a leading name in the market for manufacturing, exporting and supplying Doxorubicin Injections that can be availed at industry leading prices. Widely used for the treatment of hodgkin's disease, gastric carcinoma, bronchogenic carcinoma, acute myeloblastic leukemia and various other conditions, these injections are massively sought after. Clients can obtain the batch in safe packaging.

    Features:

    • High effectiveness
    • Enhanced shelf life
    • For intravenous use only

    Indications:


    • Wilms tumor
    • Neuroblastoma
    • Hodgkins disease
    • Gastric carcinoma
    • Hodgkins disease
    • Breast carcinoma
    • Thyroid carcinoma
    • Ovarian carcinoma
    • Malignant lymphoma
    • Lymphoblastic leukemia
    • Bronchogenic carcinoma
    • Acute myeloblastic leukemia
    • Soft tissue and bone sarcomas
    • Transitional cell bladder carcinoma

    Dosage and Administration:

    • 60-75 mg/m2 as a single intravenous injection administered every 3 weeks
    • Dose adjustment is required in hepatically impaired patients

    Additional Information:

  • Item Code: 50mg-25ml
  • Yes! I am Interested

    Paclitaxel Injection 100mg

    REQUEST CALLBACK

    Paclitaxel Injection 100mg
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    We are concerned with the manufacture, export and supply of Paclitaxel Injection 100mg that is made available in different packaging quantities. Widely used for curing ovarian cancer, breast cancer, NSCLC and aids-related kaposi sarcoma, the proffered batch of injection is massively asked for. In order to prevent harmful chemicals and contaminants, we offer the batch in tamper proof packaging.

    Features:

    • Extended shelf life
    • Accurate chemical formulation
    • High effectiveness

    Indications:

    • Ovarian Cancer
    • NSCLC
    • Breast Cancer
    • AIDS-related Kaposi Sarcoma

    Dosage and Administration:

    Ovarian Cancer:

    • For previously untreated patients with carcinoma of ovary, 1 of the following recommended regimens may be given every 3 weeks
    • Paclitaxel 175mg/m2 administered IV over 3 hrs followed by Cisplatin 75mg/m2
    • Paclitaxel 135mg/m2 administered IV over 24 hours followed by Cisplatin 75mg/m2
    • In patients previously treated with chemotherapy for carcinoma of the ovary, recommended regimen is paclitaxel 135-175 mg/m2 administered IV over 3 hours every 3 weeks.

    Breast Cancer:

    • For The adjuvant-treatment of node-positive Breast Cancer, the recommended regimen is paclitaxel 175mg/m2 IV over 3 hours every 3 weeks for 4 courses administered sequentially to doxorubicin- containing combination chemotherapy
    • After failure of initial chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy, paclitaxel 175mg/m2 administered IV over 3 hours every 3 weeks.

    NSCLC:

    • Given every 3 weeks, Paclitaxel 315 mg/m2 is administered IV over 24 hrs followed by Cisplatin 75 mg/m2

    AIDS-related Kaposi Sarcoma:

    • Paclitaxel 135 mg/m2 given IV over 3 hours every 2 weeks is recommended (dose intensity 45-50 mg /m2 /week).
    • Paclitec to patients with AIDS-related Kaposi sarcoma if the base count or subsequent neutrophil count is less than 1,000 cells /mm3, 2- Reduce the dose of Dexamethasone (as 1 of the 3 premedication drugs) to 10mg orally (instead of 20 mg orally)
    Yes! I am Interested

    View PDF

    Paclitaxel Injection 300mg

    REQUEST CALLBACK

    Paclitaxel Injection 300mg
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    Being one of the glorious names of the field, we are involved in manufacturing, exporting and supplying Paclitaxel Injection 300mg in standardized packaging. Processed under hygienic environmental conditions, the proposed compilation is massively applauded for its supreme effectiveness and enhanced shelf life. These injections play a vital role in treating NSCLC, ovarian cancer, aids-related kaposi sarcoma and breast cancer.

    Features:

    • Longer shelf life
    • Precise pH value
    • Hygienically prepared

    Indications:

    • Ovarian Cancer
    • NSCLC
    • Breast Cancer
    • AIDS-related Kaposi Sarcoma

    Dosage and Administration:

    Ovarian Cancer:

    • For previously untreated patients with carcinoma of ovary, 1 of the following recommended regimens may be given every 3 weeks
    • Paclitaxel 175mg/m2 administered IV over 3 hrs followed by Cisplatin 75mg/m2
    • Paclitaxel 135mg/m2 administered IV over 24 hours followed by Cisplatin 75mg/m2
    • In patients previously treated with chemotherapy for carcinoma of the ovary, recommended regimen is paclitaxel 135-175 mg/m2 administered IV over 3 hours every 3 weeks.

    Breast Cancer:

    • For The adjuvant-treatment of node-positive Breast Cancer, the recommended regimen is paclitaxel 175mg/m2 IV over 3 hours every 3 weeks for 4 courses administered sequentially to doxorubicin-containing combination chemotherapy
    • After failure of initial chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy, paclitaxel 175mg/m2 administered IV over 3 hours every 3 weeks.

    NSCLC:

    • Given every 3 weeks, Paclitaxel 315 mg/m2 is administered IV over 24 hrs followed by Cisplatin 75 mg/m2

    AIDS-related Kaposi Sarcoma:

    • Paclitaxel 135 mg/m2 given IV over 3 hours every 2 weeks is recommended (dose intensity 45-50 mg /m2 /week).
    • Paclitec to patients with AIDS-related Kaposi sarcoma if the base count or subsequent neutrophil count is less than 1,000 cells /mm3, 2- Reduce the dose of Dexamethasone (as 1 of the 3 premedication drugs) to 10mg orally (instead of 20 mg orally)
    Yes! I am Interested

    View PDF

    Paclitaxel Injection 30mg

    REQUEST CALLBACK

    Paclitaxel Injection 30mg
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    Backed by a team of skilled and experienced professionals, we are involved in proffering hygienically processed and packed Paclitaxel Injection 30mg. Prepared as per the existing industrial procedures, these effective injections are immensely popular for treating ovarian & breast cancer, NSCLC and aids-related kaposi sarcoma. To avoid contaminants, we provide the batch in standardized packaging.

    Features:

    • Extended shelf life
    • Correct chemical composition
    • Effective results

    Indications:

    • Ovarian Cancer
    • NSCLC
    • Breast Cancer
    • AIDS-related Kaposi Sarcoma

    Dosage and Administration:

    Ovarian Cancer:

    • For previously untreated patients with carcinoma of ovary, 1 of the following recommended regimens may be given every 3 weeks
    • Paclitaxel 175mg/m2 administered IV over 3 hrs followed by Cisplatin 75mg/m2
    • Paclitaxel 135mg/m2 administered IV over 24 hours followed by Cisplatin 75mg/m2
    • In patients previously treated with chemotherapy for carcinoma of the ovary, recommended regimen is paclitaxel 135-175 mg/m2 administered IV over 3 hours every 3 weeks

    Breast Cancer:

    • For The adjuvant-treatment of node-positive Breast Cancer, the recommended regimen is paclitaxel 175mg/m2 IV over 3 hours every 3 weeks for 4 courses administered sequentially to doxorubicin- containing combination chemotherapy
    • After failure of initial chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy, paclitaxel 175mg/m2 administered IV over 3 hours every 3 weeks

    NSCLC:

    • Given every 3 weeks, Paclitaxel 315 mg/m2 is administered IV over 24 hrs followed by Cisplatin 75 mg/m2

    AIDS-related Kaposi Sarcoma:

    • Paclitaxel 135 mg/m2 given IV over 3 hours every 2 weeks is recommended (dose intensity 45-50 mg /m2 /week)
    • Paclitec to patients with AIDS-related Kaposi sarcoma if the base count or subsequent neutrophil count is less than 1,000 cells /mm3, 2- Reduce the dose of Dexamethasone (as 1 of the 3 premedication drugs) to 10mg orally (instead of 20 mg orally)
    Yes! I am Interested

    View PDF

    Vincristine Sulfate Injection

    REQUEST CALLBACK

    Vincristine Sulfate Injection
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    We are considered a celebrated name in the business to manufacture, supply and export Vincristine Sulfate Injection that is meant for intravenous infusion only. Processed under controlled environmental conditions, these accurately composed injections are used for treating wilms tumor, neuroblastoma, hodgkins disease and rhabdomyosarcoma. We offer these injections in safe packaging.

    Features:

    • High effectiveness
    • Enhanced shelf life
    • For intravenous use only

    Indications:


    • Wilms tumor
    • Neuroblastoma
    • Hodgkins disease
    • Rhabdomyosarcoma
    • Non hodgkins malignant lymphomas (lymphocytic, mixed cell, histiocytic, undifferentiated, nodular and diffuse types)

    Dosage and Administration:

    • Adults: 1.4 mg/m2 IV once weekly
    • Children: Body wt. 10 kg or less 0.05 mg/kg once weekly and Body wt. above 10 kg= 1-2 mg/ m2 once weekly
    Yes! I am Interested

    Vincristine Sulfate Injection for Clinic

    REQUEST CALLBACK

    Vincristine Sulfate Injection for Clinic
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    We are offering wide range of Vincristine Sulfate Injection for Clinic. The offered injection is highly regarded by oncologists for being effective in treating cancer. We make it available in several compositions to fulfill the diverse requirements of the customers.

    Features:

    • High effectiveness
    • Enhanced shelf life
    • For intravenous use only

    Indications:


    • Wilms tumor
    • Neuroblastoma
    • Hodgkins disease
    • Rhabdomyosarcoma
    • Non hodgkins malignant lymphomas (lymphocytic, mixed cell, histiocytic, undifferentiated, nodular and diffuse types)

    Dosage and Administration:

    • Adults: 1.4 mg/m2 IV once weekly
    • Children: Body wt. 10 kg or less 0.05 mg/kg once weekly and Body wt. above 10 kg= 1-2 mg/ m2 once weekly
    Yes! I am Interested

    Letrozole Tablets

    Letrozole Tablets
    Yes! I am Interested


     
    X


    Explore More Products

    Contact via E-mail
    Contact via SMS
    Angel Biogenics Private Limited
    Sugam Sureja (General Manager Export)
    Tirupati Complex, First Floor Shapar, Veraval,
    Rajkot - 360024, Gujarat, India
    Call Us: 
    Call Response Rate: 83%
    Share Us :
    F G T L



    Home  |   About Us   |  Our Product Range  |  Site Map  |   Contact Us   |   Mobile Site

    © Angel Biogenics Private Limited. All Rights Reserved (Terms of Use)
    Developed and Managed by IndiaMART InterMESH Limited

    Angel Biogenics Private Limited